Menu
Search
|

Menu

Close
X

Chromadex Corp CDXC.OQ (NASDAQ Stock Exchange Capital Market)

3.48 USD
+0.09 (+2.65%)
As of Nov 21
chart
Previous Close 3.39
Open 3.35
Volume 72,972
3m Avg Volume 45,696
Today’s High 3.50
Today’s Low 3.35
52 Week High 7.24
52 Week Low 3.19
Shares Outstanding (mil) 46.09
Market Capitalization (mil) 196.82
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY18
22
FY17
21
FY16
25
FY15
22
EPS (USD)
FY18
-0.457
FY17
-0.352
FY16
-0.078
FY15
-0.077
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.60
Price to Sales (TTM)
vs sector
9.65
5.69
Price to Book (MRQ)
vs sector
7.57
5.11
Price to Cash Flow (TTM)
vs sector
--
23.53
Total Debt to Equity (MRQ)
vs sector
2.69
15.71
LT Debt to Equity (MRQ)
vs sector
1.53
11.53
Return on Investment (TTM)
vs sector
-39.31
15.05
Return on Equity (TTM)
vs sector
-40.84
16.62

EXECUTIVE LEADERSHIP

Robert Fried
President, Chief Executive Officer, Chief Operating Officer, Chief Strategy Officer, Director, Since 2018
Salary: --
Bonus: --
Kevin Farr
Chief Financial Officer, Secretary, Principal Accounting Officer and Principal Financial Officer, Since 2017
Salary: --
Bonus: --
Troy Rhonemus
Executive Vice President, Since 2018
Salary: $222,692.00
Bonus: $11,400.00
Matthew Roberts
Senior Vice President - Innovation, Chief Scientific Officer, Since 2018
Salary: --
Bonus: --
Lisa Bratkovich
Chief Marketing Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

10005 Muirlands Blvd Fl 1
IRVINE   CA   92618-2519

Phone: +1949.4190288

Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.

SPONSORED STORIES